High THC Cannabis
Phase 2
High THC Cannabis is one of 6 therapeutic programs targeting Post-Traumatic Stress Disorder, PTSD. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
5
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
5 competitors in Post-Traumatic Stress Disorder, PTSD
#DrugCompanyPhaseTrials
1Ritalin
NovartisApproved
Inderal
WWyeth-Lederle Vaccines
Phase 3
Mifeprex
DDanco
Phase 2
Psilocybin
COMPASS PathwaysPhase 2
High THC Cannabis
MMultidisciplinary Association for Psychedelic Studies
Phase 2
Typhoid Vi Polysaccharide Vaccine
NovartisPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Post-Traumatic Stress Disorder, PTSD1 trial
Phase 2 Multicenter Randomized Placebo-controlled, Double-blind, Parallel Study to Assess the Safety and Efficacy of Inhaled Cannabis in Veterans for Treatment of Posttraumatic Stress Disorder (PTSD)
Not yet recruiting·MMultidisciplinary Association for Psychedelic Studies·Phase 2·NCT07224698·320 enrolled
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for High THC Cannabis. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 2[1]